Intuitive Surgical's stock is being considered for purchase ahead of its earnings report. Some outlets view the company as a strong buy due to the growth of robotic surgery adoption, while others compare its valuation to that of competitors like Stryker. The stock has experienced a decline in 2026, but its potential for recovery and long-term growth is being discussed.